Scott LaNeve has been working in and around medical labs for over 30 years and has held high-profile leadership positions with companies such as Quest Diagnostics and Roche. Scott has also held leadership roles in a series of smaller startups and turn-arounds where the pace of business is very fast. Scott has been a national advocate for the prevention of opioid misuse through vigilant patient monitoring and has spent the last several years focused exclusively on the opioid crisis. Scott developed and launched a clinical support program which helps providers meet best practice monitoring guidelines and that program has made an impact on over 30,000 enrolled patients so far. Scott also has experience developing programs for delivering medical diagnostic testing results quickly and easily to clients, which has been critical for COVID-19 results reporting. Scott will leverage this background, building DRUGSCAN’s viral testing service ViraScan.